Eli Lilly’s Financing Decisions A. Common stock at December 31, 2001 * Authorized shares: 3,200,000,000 shares * Issued shares: 1,124,333,530 shares * Outstanding shares: 1,123.348,749 shares Preferred stock at December 31, 2001 * Authorized shares: 5,000,000 shares
B. In December 31, 2001, the company has purchased $1.41 billion of its announced $3.0 billion share repurchase program and acquired approximately 7.2 million. In connection with the share repurchase program, the company has agreements to purchase up to approximately 6.0 million shares of company stock from an independent third party at various times through the expiration of the agreements in December 2003 at prices ranging from $80 to $100 per share.
C. December 31, 2000 * Number of Common shares issued: 1,126,567,407 shares * Number of Outstanding shares issued: 1,126,560,172 shares December 31, 2001 * Number of Common shares issued: 1,124,333,530 shares * Number of Outstanding shares issued: 1,123.348,749 shares
D. 2000 * Amount per share of Dividend: 1.04 $ * Total amount of Dividends declared: 1.06 $ * 1,097,725,000 shares= 1,163,588,500 $ * Dividends paid: 1,126,000,000 $ 2001 * Amount per share of Dividend: 1.12 $ * Total amount of Dividends declared: 1.15 $ * 1,090,793,000 shares = 1,254,411,950 $ * Dividends paid: 1,207,200,000 $
E. 35.2 million of Lily stock options were exercisable in 2001 and the amount increased 9.1